Sangamo Therapeutics Inc (SGMO.OQ)
SGMO.OQ on NASDAQ Stock Exchange Global Select Market
11.68USD
10 Dec 2018
11.68USD
10 Dec 2018
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$11.68
$11.68
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
8
8
Avg. Vol
552,166
552,166
52-wk High
$27.50
$27.50
52-wk Low
$9.00
$9.00
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
| Name | Age | Since | Current Position |
|---|---|---|---|
Alexander Macrae |
55 | 2016 | President, Chief Executive Officer, Director |
Kathy Yi |
47 | 2017 | Chief Financial Officer, Senior Vice President |
Edward Rebar |
2018 | Senior Vice President, Chief Technology Officer | |
Heather Turner |
45 | 2018 | Senior Vice President, General Counsel, Secretary |
Edward Conner |
45 | 2016 | Senior Vice President and Chief Medical Officer |